SG153848A1 - Aequorin-containing compositions and methods of using same - Google Patents

Aequorin-containing compositions and methods of using same

Info

Publication number: SG153848A1
Authority: SG; Singapore
Prior art keywords: methods; aequorin; same; containing compositions; preventing
Prior art date: 2004-06-21

Application number

SG200904273-0A

Other languages

English (en)

Inventor

Mark Y Underwood

Original Assignee

Quincy Bioscience Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-21

Filing date

2005-06-21

Publication date

2009-07-29

2005-06-21 Application filed by Quincy Bioscience Llc filed Critical Quincy Bioscience Llc

2009-07-29 Publication of SG153848A1 publication Critical patent/SG153848A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)

SG200904273-0A 2004-06-21 2005-06-21 Aequorin-containing compositions and methods of using same SG153848A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/872,795 US20060229243A1 (en)	2004-06-21	2004-06-21	Aequorin-containing compositions and methods of using same

Publications (1)

Publication Number	Publication Date
SG153848A1 true SG153848A1 (en)	2009-07-29

Family

ID=35785748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200904273-0A SG153848A1 (en)	2004-06-21	2005-06-21	Aequorin-containing compositions and methods of using same

Country Status (20)

Country	Link
US (3)	US20060229243A1 (fr)
EP (2)	EP1768691B1 (fr)
JP (1)	JP4971150B2 (fr)
KR (1)	KR101213555B1 (fr)
CN (1)	CN1997383B (fr)
AU (1)	AU2005265266B2 (fr)
BR (1)	BRPI0512392B1 (fr)
CA (1)	CA2571542C (fr)
CY (1)	CY1114307T1 (fr)
DK (1)	DK1768691T3 (fr)
ES (1)	ES2422173T3 (fr)
IL (1)	IL180195A (fr)
MX (1)	MXPA06015037A (fr)
NZ (1)	NZ552274A (fr)
PL (1)	PL1768691T3 (fr)
PT (1)	PT1768691E (fr)
SG (1)	SG153848A1 (fr)
SI (1)	SI1768691T1 (fr)
WO (1)	WO2006010004A2 (fr)
ZA (1)	ZA200610688B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same
GB0625678D0 (en) *	2006-12-21	2007-01-31	Lux Biotechnology Ltd	Composition and method for detection of demineralisation
SI2262525T1 (sl)	2008-03-11	2013-03-29	Quincy Bioscience, Llc	Apoaekuorin vsebujoči sestavki in postopki njihove uporabe
JP2010143860A (ja) *	2008-12-19	2010-07-01	Chisso Corp	タンパク質の安定化剤
US20110130336A1 (en) *	2009-10-16	2011-06-02	Quincy Bioscience, Llc	Method of treating ischemic injury using apoaequorin
BR112013015605A2 (pt) *	2010-12-24	2016-10-11	Otsuka Pharma Co Ltd	método de bioanálise para detecção de substância fisiologicamente ativa
HUE035017T2 (en) *	2011-11-15	2018-03-28	Quincy Bioscience Llc	To reduce neuronal damage caused by Apoaequorin ischemia
GB201700317D0 (en)	2017-01-09	2017-02-22	Calcivis Ltd	Detection device
USD1042180S1 (en)	2020-05-28	2024-09-17	Calcivis Limited	Dental detection device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001240855A (ja) *	2000-03-01	2001-09-04	Masashi Sugimoto	生物発光方法及び発光物品
US6800492B2 (en) *	2000-06-01	2004-10-05	Institute Pasteur	Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level
WO2001096361A1 (fr) *	2000-06-12	2001-12-20	University Of Maryland Biotechnology Institute	Procede permettant de commander la liaison de la calmyrine a la preseniline
US20060229243A1 (en) *	2004-06-21	2006-10-12	Quincy Resource Group, Inc.	Aequorin-containing compositions and methods of using same

2004
- 2004-06-21 US US10/872,795 patent/US20060229243A1/en not_active Abandoned
2005
- 2005-06-21 SI SI200531724T patent/SI1768691T1/sl unknown
- 2005-06-21 EP EP05766584.6A patent/EP1768691B1/fr not_active Expired - Lifetime
- 2005-06-21 CA CA2571542A patent/CA2571542C/fr not_active Expired - Lifetime
- 2005-06-21 ES ES05766584T patent/ES2422173T3/es not_active Expired - Lifetime
- 2005-06-21 US US11/571,043 patent/US7671015B2/en not_active Expired - Lifetime
- 2005-06-21 SG SG200904273-0A patent/SG153848A1/en unknown
- 2005-06-21 MX MXPA06015037A patent/MXPA06015037A/es active IP Right Grant
- 2005-06-21 BR BRPI0512392-5A patent/BRPI0512392B1/pt active IP Right Grant
- 2005-06-21 EP EP12188025.6A patent/EP2545934B1/fr not_active Expired - Lifetime
- 2005-06-21 PT PT57665846T patent/PT1768691E/pt unknown
- 2005-06-21 NZ NZ552274A patent/NZ552274A/en not_active IP Right Cessation
- 2005-06-21 PL PL05766584T patent/PL1768691T3/pl unknown
- 2005-06-21 CN CN200580024585XA patent/CN1997383B/zh not_active Expired - Lifetime
- 2005-06-21 JP JP2007518179A patent/JP4971150B2/ja not_active Expired - Lifetime
- 2005-06-21 AU AU2005265266A patent/AU2005265266B2/en not_active Expired
- 2005-06-21 DK DK05766584.6T patent/DK1768691T3/da active
- 2005-06-21 WO PCT/US2005/021770 patent/WO2006010004A2/fr not_active Ceased
- 2005-06-21 KR KR1020077001461A patent/KR101213555B1/ko not_active Expired - Lifetime
2006
- 2006-12-19 IL IL180195A patent/IL180195A/en active IP Right Grant
- 2006-12-19 ZA ZA200610688A patent/ZA200610688B/en unknown
2010
- 2010-01-27 US US12/694,427 patent/US20100152117A1/en not_active Abandoned
2013
- 2013-06-14 CY CY20131100486T patent/CY1114307T1/el unknown

Also Published As

Publication number	Publication date
EP1768691B1 (fr)	2013-05-22
CN1997383A (zh)	2007-07-11
AU2005265266B2 (en)	2011-05-12
EP2545934A1 (fr)	2013-01-16
KR101213555B1 (ko)	2012-12-18
WO2006010004A2 (fr)	2006-01-26
US7671015B2 (en)	2010-03-02
BRPI0512392B1 (pt)	2022-12-13
CA2571542C (fr)	2014-08-19
US20080287350A1 (en)	2008-11-20
MXPA06015037A (es)	2007-07-11
ES2422173T3 (es)	2013-09-09
PT1768691E (pt)	2013-06-20
EP1768691A2 (fr)	2007-04-04
DK1768691T3 (da)	2013-07-01
ZA200610688B (en)	2007-12-27
IL180195A0 (en)	2007-06-03
CN1997383B (zh)	2011-01-05
US20100152117A1 (en)	2010-06-17
US20060229243A1 (en)	2006-10-12
AU2005265266A1 (en)	2006-01-26
PL1768691T3 (pl)	2013-09-30
KR20070070154A (ko)	2007-07-03
IL180195A (en)	2014-03-31
JP2008503581A (ja)	2008-02-07
EP2545934B1 (fr)	2014-12-10
EP1768691A4 (fr)	2010-08-04
SI1768691T1 (sl)	2013-07-31
CA2571542A1 (fr)	2006-01-26
CY1114307T1 (el)	2016-08-31
NZ552274A (en)	2010-06-25
BRPI0512392A (pt)	2008-03-11
JP4971150B2 (ja)	2012-07-11
WO2006010004A3 (fr)	2007-03-08
HK1109576A1 (en)	2008-06-13

Publication	Publication Date	Title
PL1836169T3 (pl)	2012-07-31	Kompozycje i sposoby leczenia zaburzeń związanych z proliferacją komórek
IL187382A0 (en)	2008-02-09	Bicyclic derivatives as modulators of ion channels
GB0515353D0 (en)	2005-08-31	Food
MXPA06014510A (es)	2007-09-19	Composiciones y metodos para tratar trastornos inflamatorios.
GEP20084550B (en)	2008-11-25	Substituted morpholine compounds for the treatment of central nervous system disorders
IL193080A0 (en)	2009-02-11	Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
TW200740803A (en)	2007-11-01	Heterocyclic derivatives as modulators of ion channels
TW200618817A (en)	2006-06-16	Diffractive colorants for cosmetics
MX2010003864A (es)	2010-06-01	Amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
TW200602052A (en)	2006-01-16	Azaindoles useful as inhibitors of JAK and other protein kinases
TW200612905A (en)	2006-05-01	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en)	2013-01-31	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EA201070423A1 (ru)	2010-10-29	Диарильные соединения оксадиазолов
MX2010003009A (es)	2010-04-30	Piridil sulfonamidas como moduladores de canales ionicos.
TW200714277A (en)	2007-04-16	Methods and compositions for altering cell fuction
GEP20115201B (en)	2011-04-11	Cinnamoyl-piperazine derivatives and their use as par- i antagonists
ZA200702375B (en)	2009-03-25	Quinazolines useful as modulators of ion channels
IL205696A0 (en)	2010-11-30	Heterocyclic derivatives, compositions comprising the same and uses thereof
CY1114307T1 (el)	2016-08-31	Συνθεσεις που περιεχουν αικουορινη και μεθοδοι που τις χρησιμοποιουν
TW200724140A (en)	2007-07-01	Hydantoin compounds
TW200716091A (en)	2007-05-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
CL2008003602A1 (es)	2009-10-09	Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
TW200700064A (en)	2007-01-01	Novel compounds
MX2010009753A (es)	2010-09-30	Composiciones que contienen apoaecuorina y metodos de uso de las mismas.
MXPA05011699A (es)	2006-01-23	Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.